Galaxy Diagnostics
Galaxy Diagnostics, based in NC, USA, specializes in detecting Bartonella, a bacteria causing zoonotic infections and complications in HIV patients.
Founded
2009Galaxy Diagnostics, based in NC, USA, specializes in detecting Bartonella, a bacteria causing zoonotic infections and complications in HIV patients.
Founded in Morrisville, North Carolina, Galaxy Diagnostics is an early-stage infectious disease diagnostic company with a core mission to improve the detection of Bartonella, a bacteria responsible for zoonotic infections. The company aims to enhance public health by providing accurate and reliable diagnostic solutions, particularly for individuals who work and live with animals and are at higher risk of infection. Galaxy Diagnostics offers advanced testing services that utilize cutting-edge technology to identify Bartonella and other vector-borne pathogens.
Notable figures affiliated with Galaxy Diagnostics include experts in infectious diseases and zoonotic infections. The company has attracted attention from investors focused on innovative healthcare solutions. Key achievements include the development of highly sensitive diagnostic tests that have significantly improved the detection rates of Bartonella infections. Overall, Galaxy Diagnostics has made a substantial impact on public health by addressing a critical gap in the diagnosis of vector-borne diseases, thereby contributing to better patient outcomes and awareness.
Companies similar to Galaxy Diagnostics include Day Zero Diagnostics, Karius, Specific Diagnostics and NAT Diagnostics.
Galaxy Diagnostics was founded in 2009.
Galaxy Diagnostics' headquarters is located in Durham, NC, US.
As of Jul 1, 2023, Galaxy Diagnostics has raised a total of $550.8k (USD).
Galaxy Diagnostics has 30 employees as of Feb 5, 2024.
Specific Diagnostics
